Elm Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-3,855
| Closed | -$228K | – | 80 |
|
|
2021
Q4 | $228K | Buy |
+3,855
| New | +$191K | 0.13% | 86 |
|
|
2021
Q1 | – | Sell |
-4,292
| Closed | -$158K | – | 209 |
|
|
2020
Q4 | $158K | Buy |
+4,292
| New | +$157K | 0.1% | 92 |
|
|
2020
Q1 | – | Sell |
-8,207
| Closed | -$305K | – | 87 |
|
|
2019
Q4 | $305K | Hold |
8,207
| – | – | 0.19% | 67 |
|
|
2019
Q3 | $280K | Sell |
8,207
-243
| -3% | -$8.84K | 0.19% | 71 |
|
|
2019
Q2 | $347K | Sell |
8,450
-369
| -4% | -$14.7K | 0.24% | 62 |
|
|
2019
Q1 | $355K | Sell |
8,819
-548
| -6% | -$21.9K | 0.25% | 60 |
|
|
2018
Q4 | $388K | Hold |
9,367
| – | – | 0.31% | 55 |
|
|
2018
Q3 | $392K | Buy |
9,367
+1,881
| +25% | +$72.4K | 0.26% | 57 |
|
|
2018
Q2 | $258K | Sell |
7,486
-368
| -5% | -$12.6K | 0.2% | 67 |
|
|
2018
Q1 | $264K | Sell |
7,854
-317
| -4% | -$10.9K | 0.2% | 65 |
|
|
2017
Q4 | $281K | Sell |
8,171
-316
| -4% | -$10.8K | 0.21% | 67 |
|
|
2017
Q3 | $287K | Hold |
8,487
| – | – | 0.23% | 63 |
|
|
2017
Q2 | $270K | Hold |
8,487
| – | – | 0.22% | 64 |
|
|
2017
Q1 | $275K | Buy |
8,487
+738
| +10% | +$23.3K | 0.23% | 65 |
|
|
2016
Q4 | $239K | Hold |
7,749
| – | – | 0.22% | 69 |
|
|
2016
Q3 | $249K | Sell |
7,749
-184
| -2% | -$6.15K | 0.23% | 67 |
|
|
2016
Q2 | $265K | Buy |
+7,933
| New | +$253K | 0.25% | 65 |
|
|
2016
Q1 | – | Sell |
-7,090
| Closed | -$217K | – | 76 |
|
|
2015
Q4 | $217K | Sell |
7,090
-659
| -9% | -$20.7K | 0.21% | 67 |
|
|
2015
Q3 | $231K | Sell |
7,749
-422
| -5% | -$13.5K | 0.24% | 61 |
|
|
2015
Q2 | $260K | Hold |
8,171
| – | – | 0.24% | 60 |
|
|
2015
Q1 | $270K | Sell |
8,171
-579
| -7% | -$18.4K | 0.25% | 59 |
|
|
2014
Q4 | $259K | Sell |
8,750
-738
| -8% | -$21.2K | 0.24% | 60 |
|
|
2014
Q3 | $266K | Sell |
9,488
-722
| -7% | -$20.3K | 0.25% | 59 |
|
|
2014
Q2 | $288K | Sell |
10,210
-211
| -2% | -$6.01K | 0.27% | 55 |
|
|
2014
Q1 | $318K | Sell |
10,421
-211
| -2% | -$6.29K | 0.31% | 54 |
|
|
2013
Q4 | $309K | Buy |
+10,632
| New | +$309K | 0.3% | 55 |
|
Other funds holding PFE
Elm Advisors's PFE Position: Q1 2022 in Review
Elm Advisors sold out of Pfizer (PFE) in Q1 2022, closing a stake of 3,855 shares — an estimated $228K sold.
Elm Advisors first reported a position in PFE in Q4 2013 and held it in 26 quarters. The position peaked at $392K in Q3 2018. 3,195 funds tracked by Wall St. Rank hold PFE as of Q1 2022.
- Elm Advisors reported no remaining Pfizer position as of Q1 2022 after selling out during the quarter.
- Elm Advisors sold 3,855 Pfizer shares in Q1 2022, an estimated $228K.
- Elm Advisors first reported a position in Pfizer in Q4 2013 and held it in 26 quarters.
- Elm Advisors's Pfizer position peaked at $392K in Q3 2018.
- 3,195 funds tracked by Wall St. Rank held Pfizer as of Q1 2022.
Based on Elm Advisors's 13F filing for Q1 2022, filed 1 Apr 2022.